GlassScriptPhysician profile
Joshua Kessler
NPI 1831169127
$958.45
in general payments reported to CMS, 2019-2025
14 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $179 · 2021: $37.96 · 2022: $128 · 2023: $96.10 · 2024: $149 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $195.66 | 2019-2022 | |
| Medtronic USA, INC. | $173.95 | 2019-2020 | |
| Genzyme Corporation | $117.77 | 2022-2024 | |
| Acclarent, INC | $92.48 | 2019-2022 | |
| Medtronic, INC. | $85.13 | 2024-2025 | Propel |
| Smith+Nephew, INC. | $57.00 | 2019-2021 | |
| Glaxosmithkline, LLC. | $48.52 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $45.79 | 2023-2024 | Dupixent |
| Olympus America INC. | $33.83 | 2023 | Olympus |
| Intersect Ent, INC. | $29.26 | 2020 | |
| Inspire Medical Systems, INC. | $23.58 | 2025 | Inspire |
| Hikma Pharmaceuticals USA | $20.66 | 2023 | Ryaltris |
| Optinose US, INC. | $19.87 | 2024 | |
| Aerin Medical INC. | $14.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Kessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.